- having regard to the European and Developing Countries Clinical Trials Partnership (EDCTP), Special Programme for Research and Training in Tropical Diseases (TDR), Global Alliance for TB Drug Development (TB Alliance), International AIDS Vaccine Initiative (IAVI), International Partnership for Microbicides (IPM), European Malaria Vaccine Initiative (EMVI), Global Alliance for Vaccines and Immunization (GAVI)/The Vaccine Fund, Medicines for Malaria Venture (MMV), Roll Back Malaria (RBM) Partnership and the Drugs for Neglected Diseases Initiative (DNDi) and others who are working to research and develop drugs for neglected diseases,
- gezien het European and Developing Countries Clinical Trials Partnership (EDCTP), het Special Programme for Resea
rch and Training in Tropical Diseases (TDR), de Global Alliance for TB Drug Development (TB Alliance), het International AIDS Vaccine Initiative (IAVI), het International Partnership for Microbicides (IPM), het European Malaria Vaccine Initiative (EMVI), de Global Alliance for Vaccines and Immunization (GAVI), The Vaccine Fund, Medicines for Malaria Venture (MMV), Roll Back Malaria Partnership (RBM), het Drugs for Neglected Diseases Initiative (DNDi) en andere organisaties die werken aan onderzoek op het gebied van verwaarlo
...[+++]osde ziekten en de ontwikkeling van geneesmiddelen hiervoor,